leading phase

leading phase

[′lēd·iŋ ¦fāz]
(electricity)
In three-phase power measurement, the phase whose voltage is leading upon that of one of the other phases by 120°.
Mentioned in ?
References in periodicals archive ?
David has a strong track record of leading Phase 2-stage companies like Akari.
Our radio frequency (RF) microelectronic solutions boast industry leading phase noise performance and high packaging density.
In 2008, Pitkin got a stake in West Linapacan in exchange for its leading Phase 2 redevelopment work in West Linapacan.
a contract formulation, development and manufacturing company of oral solid dosage pharmaceuticals, has a reputation as one of the leading Phase I-III clinical trial materials manufacturers in the United States.
Simon Linford, executive chairman of Linford Group, said: "We are proud to be leading phase one in the restoration of this magnificent example of 15th century architecture.
The so-called digital PD produces a series of positive or negative current pulses corresponding to a lagging or leading phase difference between the divided-down feedback signal and the reference.
ADI), a global leader in high-performance semiconductors for signal-processing applications and leading provider of RF ICs (radio frequency integrated circuits), today announced the release of a PLL synthesizer that offers leading phase noise performance.
Other factors included results from TriQuint's Defense Advanced Research Projects Agency (DARPA) Wide Bandgap Semiconductor (WBGS) RF GaN program, in which TriQuint led Phase II and is leading Phase III.
As a leading Phase I through IV CRO with locations in 31 countries, Omnicare Clinical Research manages trials for pharmaceutical, biotechnological, nutraceutical and medical device companies of all sizes and specialties.
These new devices are based on ADI's PLL/VCO synthesizer, mixer and modulator technologies, which offer the industry's leading phase noise performance, power consumption and linearity for smaller form factor and higher density macro, micro, and picocell base stations.
Chapters 4, 5 and 6 provide a review of the leading phase I, II and III clinical stage partnering deals since 2000, respectively.